CreativeOne Wealth’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
UCFA
GKWIM
YIA
CreativeOne Wealth's PBE Position: Q2 2026 in Review
CreativeOne Wealth reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 11% in Q2 2026, selling an estimated $109K and leaving 10,893 shares worth $976K. The position accounts for 0.02% of the portfolio, ranked #588.
CreativeOne Wealth first reported a position in PBE in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.61M in Q1 2024. 105 funds tracked by Wall St. Rank hold PBE as of Q2 2026.
- CreativeOne Wealth held 10,893 shares of Invesco Biotechnology & Genome ETF worth $976K as of Q2 2026.
- CreativeOne Wealth sold 1,326 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $109K.
- Invesco Biotechnology & Genome ETF made up 0.02% of CreativeOne Wealth's portfolio in Q2 2026, its #588 holding.
- CreativeOne Wealth first reported a position in Invesco Biotechnology & Genome ETF in Q3 2022 and has held it in 16 quarters since.
- CreativeOne Wealth's Invesco Biotechnology & Genome ETF position peaked at $2.61M in Q1 2024.
- 105 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.
Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.